Archive for the ‘research’ Category

Magic Trick Reveal: How To Get Perfect Efficacy From a ‘Vaccine’ That Doesn’t Work. Two White Papers Call to Halt COVID Shots, But FDA Approves Non-mRNA COVID Shot

https://kirschsubstack.com/p/the-big-magic-trick-revealed?

The big magic trick revealed!

How can you get near perfect efficacy from a vaccine that doesn’t work? Thanks to Professor Jeffrey Morris, I now know the magic trick too! This one had me fooled me for years.

Steve Kirsch
May 16, 2025
The Secret Truth Behind Penn & Teller: Fool Us

I like Penn and Teller. But they don’t know jack about vaccines. Check out this video they did. They should apologize and re-do the video to tell the truth. YouTube will ban it though.

Executive Summary

If you have a policy of COVID testing where it is mandatory to test the unvaccinated 2x/week but the vaccinated can totally skip testing, this can massively skew all studies based on that data.

I just found out this was the case in the Czech Republic which is the only country where we have record level data.

That explains a lot, doesn’t it? A testing policy like that can make an ineffective vaccine close to perfect.

Bottom line: the only honest way to see if the vaccine worked is to compare the whole period all-cause mortality between those who got the shots and those who did not. Then you learn the truth.

Guess what? There isn’t a single study that does this.Zero. Zip. Nada.

So I calculated it for the Czech Republic. It shows that the vaccines should be stopped. But you already knew that, didn’t you?

And if you can’t get COVID, you can’t die from COVID!

BAM! The magic trick has been revealed. The next time you want to make a vaccine super effective, there is nothing like deploying a differential testing policy like this.

Therefore, in Czechia, you get a near perfect vaccine and can write papers about it and nobody is the wiser.  (See link for article)

_______________

**Comment**

These tactics need to be continually exposed for what they are: false and misleading – constituting scientific fraud.  Those in public health should be reviewing these things before they roll out a drug or medical product of any kind.

Hirsch then shows a table (to access, click top link) that shows when you actually compare whole period all-cause mortality between the injected and the non-injected you discover the shots are killing people.  But, reality is already showing this for those paying attention.

For more:

People have been shouting about these death shots for years.  There’s plenty of published science showing the myriad of problems.

Two White Papers Call For COVID Shot Halt

The IPAK-EDU White Paper 2025-ENDEUA states that when corrected efficacy curves and suppressed risks are taken into account, the mRNA covid shots fail the EUA standard.  The shots were based upon interim data from large-scale Phase III trials. The legal standard under §564 of the Federal Food, Drug, and Cosmetic Act requires that a product may be authorized for emergency use only if it is “reasonable to believe” that the product “may be effective” against a life-threatening condition, that the known and potential benefits outweigh the known and potential risks, and that no adequate alternatives are available. This report  demonstrates, through a rigorous retrospective analysis, that these criteria were never met.  

Go here to listen to Dr. Jeyanthi Kunadhasan, an Australian anesthesiologist and perioperative physician who was terminated from her hospital position after questioning the risk-benefit profile of COVID-19 vaccines in healthy individuals. Following her dismissal, she joined a group of international medical volunteers tasked with reviewing the 500,000+ pages of internal Pfizer documents released as part of a court-ordered FOIA request. This effort was coordinated by DailyClout and Dr. Naomi Wolf. As a result of that work, Dr. Kunadhasan has become one of the foremost experts on Pfizer’s pivotal mRNA vaccine trial, focusing specifically on discrepancies in reported deaths and adverse events.

What Dr. Kunadhasan uncovers raises grave questions about data integrity, regulatory failure, fraud, and the validity of the FDA’s EUA for the Pfizer-BioNTech COVID-19 shot.

And yet another White Paper is calling for an urgent halt on self-amplifying RNA ‘vaccine’ deployment until comprehensive safety studies are done to address contagiousness risks.  The paper discusses the significant theoretical risk including contagiousness through shedding, sexual transmission, and recombination with wild-type viruses.

FDA Commissioner Dr. Marty Makary and head of FDA’s Center for Biologics Evaluation and Research, Dr. Vinay Prasad, note that a number of other countries such as Australia and Germany only recommend the clot shots to certain populations while the U.S. has taken a ‘one size fits all’ approach because experts have argued Americans are too stupid to understand age-and risk-based recommendations.

But, even this approach ignores the elephant in the room: there are treatments for COVID which means a ‘vaccine’ isn’t even needed.  Then, there’s the fact they have negative efficacy.

What more is it going to take?

Evidently, a lot more……

The Food and Drug Administration issued an approval for Novavax’s Covid-19 ‘vaccine.’ This is the only non-mRNA vaccine.

The vaccine was approved for adults aged 65 and older and individuals aged 12 to 64 with at least one underlying health condition that increases their risk for severe COVID-19 outcomes. Reading the clinical trials prompts serious questions.

The trials included populations that had a single dose and populations that had two doses. The trials showed a reduction in symptomatic Covid 7 days after the second dose. But the FDA didn’t approve two doses. They only approved one. So is one dose even effective at all at preventing Covid? We don’t know, that wasn’t tested.  (Is this sounding familiar yet?)

There is also a noted risk of myocarditis and heart inflammation. There was also at least one vaccine recipient with “a serious event of Guillain Barré syndrome reported 9 days following the shot.  The FDA notes that Novavax has to follow up on any further cases if they observe it.

The FDA is also supposed to follow up on how the vaccine does when it is shipped to patients. They must submit a study called “Shipping Evaluation of SARS-CoV-2 rS (JN.1 Vaccine) Drug Product in Pre-Filled Syringe (PFS) Finished Good Presentation” by July of this year.

They approve vaccines not knowing how they will fare once they are shipped to doctor’s offices. They test it on us.

Don’t forget the low prevalence of Covid.

There is good news: there are at least 16 states with pending bills seeking to ban the clot shot mandates, establish a ‘vaccine’ bill of rights, or prohibit any immunization containing mRNA material.  Some bills would require manufacturers to label foods containing mRNA, according to data compiled by Bloomberg Government.

More than 2,500 ‘vaccine’-related bills have been introduced since 2021.

And top FDA official just disclosed she never got the clot shot due to her concerns about biodistribution.  She was concerned about excretion in breast milk since she was pregnant during the COVID ‘pandemic.’  When asked if information has emerged that validates her choice, said she thinks it does, but wanted to go on record that she was not speaking on behalf of the FDA.  

Researchers reported in a 2022 paper that messenger ribonucleic acid, which is in the Pfizer and Moderna COVID-19 shots, was detected in human breast milk. Another paper, in 2023, detailed similar findings.

Pfizer and Moderna did not return requests for comment.

And ‘Dilbert’ comic strip creator, Scott Adams, just admitted to having the same aggressive turbo cancer as former President Biden.

“The smartest, happiest people are the ones who didn’t get the vaccination, and they’re still alive.” ~ Scott Adams, Dilbert creator

It’s getting hot in the kitchen, folks.

Category:

Activism, research, vaccines

How Are MS & Chronic Lyme Related?

Although this article is about MS, I wanted to post this information from Dr. Makis on fibromyalgia since both have many similar symptoms:  https://makismd.substack.com/p/ivermectin-and-fibromyalgia-testimonials?

In short, fibromyalgia patients are experiencing great relief, and even cure with ivermectin.  Many are stating their pain is entirely or nearly gone.  A few MS patients claim ivermectin cured their MS.

https://www.lymedisease.org/multiple-sclerosis-chronic-lyme/

How are multiple sclerosis and chronic Lyme related?

By Bill Rawls, MD

April 21, 2025

Multiple sclerosis (MS) is a disease where the immune system attacks the protective covering (called myelin) around nerves in the brain and spinal cord.

Myelin acts like an insulator to keep nerves from touching each other and shorting out, much like the plastic coating on a copper wire.

This damage disrupts nerve signals, leading to symptoms such as fatigue, muscle weakness, numbness, vision problems, and coordination difficulties.

Undoubtedly, plenty of people who identify as having chronic Lyme disease struggle with these same symptoms. And demyelination of nerves has been documented for Lyme disease. Beyond that, many people with MS test positive for Borrelia, the Lyme bacteria. So what distinguishes MS from chronic Lyme?

The answer: arbitrary cut-offs.

So how do we differentiate?

There is no single test that is specific for MS. The diagnosis of MS is made using a combination of clinical evaluation, imaging, such as MRI, and laboratory tests of blood and spinal fluid.

If all of the findings are deemed significant enough by the clinician evaluating the patient, then the diagnosis of MS is made and the patient qualifies for treatment.

This means that a person could have all of the symptoms, and some or all of the findings, but not to the degree that would qualify for a diagnosis of MS.

That person might end up being diagnosed with some other neurological condition, fibromyalgia, or maybe wouldn’t get a diagnosis at all. Chronic Lyme disease is unlikely because it isn’t a diagnosis recognized by the conventional medical community.

No diagnosis, no treatment. But maybe that’s not such a bad thing.

Getting to the root cause

There are numerous drugs for treatment of MS. They work by blocking inflammation or blocking the immune system’s assault on myelin. The benefits are marginal at best and they carry significant side effects.

What the drugs don’t do is address why the body is attacking myelin in the first place. Without getting to the root causes of the problem, patients typically don’t get well. They live in a compromised state of relying on medications to mask the symptoms of their illness.

When you start looking for underlying causes, you’ll find that MS is listed as multifactorial. In other words, it’s not one specific cause, but rather multiple variable causes. This is also true of other chronic illnesses, including chronic Lyme disease.

A review paper published in the 2023 edition of the journal, NeuroSci, cataloged some of the known risk factors for MS that may be causative. These risk factors can be grouped into five categories.

  • Diets rich in processed foods and saturated fat, but low in vegetables and fruit
  • Chronic mental stress with inadequate sleep
  • Smoking or chronic exposure to other toxic substances
  • Sedentary lifestyle
  • Certain myelin-scavenging microbes, including (but not limited to) Chlamydia pneumoniae, Epstein-Barr Virus (EBV), Human Herpesvirus-6 (HHV-6), Mycoplasma pneumoniae and other mycoplasma species, and Borrelia burgdorferi

While the review didn’t go as far as defining how these factors might come together to cause MS, it doesn’t take much imagination to figure out a possible scenario.

A plausible explanation for MS

Myelin is contained within specialized cells called oligodendrocytes, which wrap around the shaft of a nerve to insulate it. Each of these microbes are known to invade oligodendrocytes to scavenge myelin as a resource for replication. While this provides one possible link to MS, that’s not the end of the story.

Evidence shows that the microbes can go dormant inside an oligodendrocyte after they invade it. Intracellular dormancy is a common survival mechanism used by many host-dependent microbes. It has been documented for borrelia and all the Lyme coinfections. Dormancy allows microbes to survive when conditions aren’t favorable for growth — in other words, when the cells they’ve invaded are healthy.

When cells are weakened by chronic stress factors — poor diet, chronic exposure to toxic substances, unrelenting mental stress and poor sleep, being sedentary — dormant microbes are able to reactivate, consume the cell, and then emerge to infect adjacent cells.

The immune system reacts by attacking the oligodendrocytes where microbes are emerging, in the process compounding the damage.

This is also a plausible explanation for chronic Lyme disease. The question remains: Why do some people progress to more advanced symptoms that are ultimately defined as MS?

The answer may be genetics. A variety of genetic mutations are common among people diagnosed with MS. You can’t do anything about genetic mutations, of course, but you can do something about the root causes of the problem.

A natural solution for MS and chronic Lyme

One obvious part of the solution is minimizing stress factors that weaken cells. Not surprisingly, there are many documented cases of people who went into stable remission from MS after modifying their health habits.

Improved health habits alone, however, don’t completely address the microbe factor. Fortunately, there is one thing that does — and it’s not antibiotics or other drugs.

Certain medicinal herbs demonstrate antimicrobial and immunomodulating properties that offer the potential for an ideal solution to support recovery from MS. They are already used widely for chronic Lyme disease and supported by sound evidence.

Among numerous studies, a study from Johns Hopkins University showed that certain herbs — cryptolepis, Japanese knotweed, and Chinese skullcap — were more effective for killing Borrelia than antibiotics.

Unlike an antibiotic, however, which is a single chemical agent specific for only certain microbes, an herb contains hundreds of chemical substances that act as a chemical defense system against a wide range of microbes, including bacteria, viruses, protozoa, and yeasts.

Never just one

This is important because it’s never just one microbe possibility. People identifying as having chronic Lyme disease typically test positive for co-infections. Chronic Lyme co-infections associated with demyelination include Chlamydia pneumoniae, Epstein-Barr Virus (EBV), Human Herpesvirus-6 (HHV-6), Mycoplasma pneumoniae and other mycoplasma species.

But these are just the ones that have been identified so far — there are probably many others.

Combining multiple herbs extends the range of coverage. This is possible because the potential for toxicity of the most commonly used herbs in Lyme protocols is inherently low.

Medicinal herbs and mushrooms that are commonly included in chronic Lyme protocols that could also be beneficial for MS recovery include:

  • Japanese knotweed (Polygonum cuspidatum)
  • Cat’s claw (Uncaria tomentosa)
  • Chinese skullcap (Scutellaria baicalensis).
  • Cryptolepis (Cryptolepis sanguinolenta)
  • Andrographis (Andrographis paniculata)
  • Reishi (Ganoderma lucidum)
  • Cordyceps (Cordyceps sinensis)
  • Berberine or berberine-containing herbs
  • Red sage (Salvia miltiorrhiza)
  • Rehmannia (Rehmannia glutinosa)

Very importantly, the complex chemistry of herbs and medicinal mushrooms also protects cells from a wide range of toxic threats, including free radicals, foreign toxic substances, and harmful radiation. This applies to all cells in the body, including cells that make up the nervous system.

Immunomodulators

The medicinal herbs and mushrooms listed are classified as immunomodulators, meaning they upregulate underactive parts of the immune system and downregulate overactive portions of the immune system. This is important for reducing inflammation and calming the autoimmune response.

A final advantage of antimicrobial herbs is specificity for pathogens. The antimicrobial properties of herbs and medicinal mushrooms are selective for pathogens, but do not disrupt normal flora in the gut and other areas of the body.

Low toxicity and low potential to disrupt the gut microbiome means that herbal therapy can be used for extended durations, months or even years, which is often what it takes for complete recovery.

What this all means is that therapy — with a targeted endpoint of wellness, not managed illness — can be started with or without having a formal diagnosis.

With over 30 years of medical experience, Dr. Bill Rawls specializes in the holistic treatment of chronic illnesses, particularly Lyme disease. His personal journey with Lyme disease inspired his mission to empower others with the knowledge and tools needed to regain their health naturally. Learn more about Dr. Rawls’ approach to treating chronic illness with herbal therapy at RawlsMD.com.

References

An X, Bao Q, Di S, et al. The interaction between the gut microbiota and herbal medicines. Biomed Pharmacother. 2019;118:109252.

Anderson C, Brissette CA. The Brilliance of Borrelia: Mechanisms of Host Immune Evasion by Lyme Disease-Causing Spirochetes. Pathogens. 2021;10(3):281.

Berer K, Mues M, Koutrolos M, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479(7374):538-541.

Bjornevik K, Münz C, Cohen JI, Ascherio A. Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nat Rev Neurol. 2023;19(3):160-171.

Branton WG, Lu JQ, Surette MG, et al. Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis. Sci Rep. 2016;6:37344.

Eisenreich W, Rudel T, Heesemann J, Goebel W. Persistence of Intracellular Bacterial Pathogens-With a Focus on the Metabolic Perspective. Front Cell Infect Microbiol.

Feng J, Leone J, Schweig S, Zhang Y. Evaluation of Natural and Botanical Medicines for Activity Against Growing and Non-growing Forms of B. burgdorferi. Front Med (Lausanne). 2020;7:6.

Fritzsche M. Chronic Lyme borreliosis at the root of multiple sclerosis–is a cure with antibiotics attainable? Med Hypotheses. 2005;64(3):438-448.

Greening C, Grinter R, Chiri E. Uncovering the Metabolic Strategies of the Dormant Microbial Majority: towards Integrative Approaches. mSystems. 2019;4(3):e00107-19.

Ivanova MV, Kolkova NI, Morgunova EY, et al. Role of Chlamydia in multiple sclerosis. Bull Exp Biol Med. 2015;159(5):646-648.

Kriesel JD, et al. Spectrum of Microbial Sequences and a Bacterial Cell Wall Antigen in Primary Demyelination Brain Specimens Obtained from Living Patients. Sci Rep. 2019 Feb 4;9(1):1387.

Landry RL, Embers ME. The Probable Infectious Origin of Multiple Sclerosis. NeuroSci. 2023;4(3):211-234.

Libbey JE, Cusick MF, Fujinami RS. Role of pathogens in multiple sclerosis. Int Rev Immunol. 2014;33(4):266-283.

Livengood JA, Gilmore RD Jr. Invasion of human neuronal and glial cells by an infectious strain of Borrelia burgdorferi [published correction appears in Microbes Infect. 2015 Jun;17(6):e1]. Microbes Infect. 2006;8(14-15):2832-2840.

Pender M. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis. Neuroscientist. 2011;17(4):351-367.

Rittershaus ES, Baek SH, Sassetti CM. The normalcy of dormancy: common themes in microbial quiescence. Cell Host Microbe. 2013;13(6):643-651.

Thakur A, Mikkelsen H, Jungersen G. Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies. J Immunol Res. 2019;2019:1356540.

Toledo A, Benach JL. Hijacking and Use of Host Lipids by Intracellular Pathogens. Microbiol Spectr. 2015;3(6):10.1128/microbiolspec.VMBF-0001-2014.

_______________

**Comment**

A few points:

  • The Johns Hopkins study was in vitro, or the lab, which may not transfer over to the human body.
  • Antibiotics of daptomycin, doxycycline, and cefuroxime were used as controls at a final concentration of 5 μg/ml.  I’m not sure how this translates to oral dosages given patients, but according to Burrascano, dosages matter greatly.  It could be that these dosages were not high enough.
  • Doxy is a great front-line drug due to its action against many coinfections, but it is not the best and only drug to treat Lyme disease.
    • Eva Sapi found that while the use of doxy reduced spirochetal structures ~90%, round body forms increased about twofold.What this means is these round forms will simply lie and wait until conditions are better to reemerge. She found that tinidazole was the only antibiotic that reduced viable organisms by ~90%.  Recent research showed piperacillin effectively cured mice of Lyme at a dose 100 times smaller than doxycycline with virtually no impact on resident gut microbes.
So, for anyone paying attention, doxy has its limitations and all experienced Lyme literate doctors use multiple antibiotics in a combination therapy.

This, right here, is why mainstream medicine and research are worthless because this complex illness is treated as a one pathogen, one drug illness when typically more than one pathogen involved, and to complicate it further, the pathogens have multiple forms (pleomorphism) and strains that need to be addressed.

  • Daptomycin is an antibiotic that has been utilized recently in combination therapies. In a study through Johns Hopkins, when combined with doxycycline and ceftriaxone, daptomycin effectively cleared Lyme disease infection in vitro as well as in mice. However, daptomycin is relatively expensive and only available intravenously.  Notice it’s effectiveness is due to being used in a combo therapy.  I would say this is true of ALL antibiotics and why single antibiotics were not successful in the Johns Hopkins study Rawls refers to.
  • While cefuroxime has been found to have a minimum bactericidal concentration (MBC) similar to doxycycline; out of three borrelia species tested, two were susceptible while the third (borrelia hermsii) was less susceptible. The three antibiotics with similar MBCs in vitro, i.e., cefuroxime, doxycycline, and amoxicillin, demonstrated comparable activities in preventing borreliosis in B. burgdorferi-challenged hamsters (50% curative doses = 28.6, 36.5 and 45.0 mg/kg, respectively). So cefuroxime is far from perfect either when used alone.  Source

Using single antibiotics is really doing an injustice to what is known about successful treatment for Lyme since tindy is the most effective drug overall and combination drug protocols are by far the most effective.

Please remember too that Dr. Rawls manufactures and sells herbs and is financially compensated.

Don’t misunderstand – I’m not opposed to herbs.  I’ve used many myself and know of patients who have done well on them.  I just don’t want you to believe they are perfect or the only answer, either.  It takes everything AND the kitchen sink for this crap so keep an open mind.  And herbs are not harmless – there are interactions with other drugs as well as toxicity.

Nothing is ever simple.

For more:

Category:

Herbs, Lyme, research, Treatment

Why Doctor Treated Patient for Lyme – Even When His Test Was Negative

https://danielcameronmd.com/treated-lyme-negative-test/

Why I Treated Him for Lyme—Even When His Test Was Negative

Posted By: Dr. Daniel Cameron
May 13, 2025

Patients Deserve an Explanation

One of the most common—and most important—questions I hear from patients is:
“If my Lyme test is negative, why are you still treating me?”

It’s a fair question. And if you’re asking it, you deserve a clear and compassionate answer. The truth is, when it comes to Lyme disease, test results don’t always tell the full story.

Let’s break down why.

Lyme Disease Testing Isn’t Always Reliable

The standard test used to diagnose Lyme disease is called the two-tier system. It includes an ELISA screening test followed by a Western blot if the first result is positive. But this system is far from perfect—especially when the infection is in its early or late stages.

Here’s what you should know:

  • Early in the infection, your body may not have produced enough antibodies yet to trigger a positive result
  • Some patients never produce detectable antibodies at all
  • Co-infections like Babesia or Bartonella are not picked up by this test
  • Many rashes don’t appear in the textbook “bulls-eye” pattern—or don’t appear at all
So yes—you can absolutely have Lyme disease, even if your test is negative. And unfortunately, this is more common than many realize.

In Medicine, We Don’t Wait for Disease to Get Worse

In most areas of healthcare, we don’t wait for a serious event before we start treatment.

  • We don’t wait for a stroke to treat high blood pressure
  • We don’t wait for vision loss to manage diabetes
  • We don’t wait for full organ failure to address chronic kidney disease

We act early—because we know that early treatment improves outcomes. So why does Lyme disease often get treated differently?

When it comes to Lyme, many patients are told to “wait and see”—even when the symptoms are clear and distressing.

Waiting Is Not a Neutral Decision

Here’s what I tell my patients:
Waiting is not harmless. It’s a medical decision with consequences.

Delaying treatment can allow symptoms to worsen. It can allow the infection to persist or spread. In some cases, patients who were told to wait eventually end up with a label: Post-Treatment Lyme Disease Syndrome (PTLDS)—a condition where symptoms linger long after the initial infection was treated, or in some cases, never properly treated at all.

What if we had treated earlier? Could we have prevented months—or even years—of suffering?

In many cases, the answer is yes.

Clinical Judgment Is Not Guesswork

When I decide to treat someone for Lyme disease despite a negative test, it’s not a random decision. It’s based on:

• The full pattern of your symptoms

• Your medical history

• Your response to prior treatments

• Known or likely tick exposure

• And experience with thousands of Lyme patients

This is called clinical judgment. It’s a core part of good medical practice. I don’t ignore science—I apply it in context. Because Lyme doesn’t always follow the rules, and neither should we when those rules are failing real people.

You Know When Something Feels Wrong

I’ve met patients who’ve been told their symptoms are “just stress” or “hormonal” or “all in their head.” But they know their bodies. They’ve tracked their fatigue, their joint pain, their cognitive changes. They’ve seen something shift—and they’re right to speak up about it.

Many of those patients improve once treatment begins, even if their test results never confirmed the diagnosis. That’s not luck. That’s Lyme disease showing up in real life—even when it doesn’t show up in the lab.

It’s Time to Rethink How We Treat Lyme

We’re in a new era of medicine. Patients are more informed, more proactive, and more in tune with their own health than ever before. But too often, our Lyme diagnostic standards are stuck in the past—waiting for certainty while people lose months or years of their lives to untreated illness.

We need to bring clinical judgment back into focus. We need to listen more, wait less, and treat Lyme disease with the urgency it deserves.

Final Thoughts

If you’ve been told your test is negative, but you’re still struggling with symptoms—please know this:
You’re not imagining it. You’re not overreacting. And you’re not alone.

In my practice, I treat the whole patient—not just the lab result. Because when it comes to Lyme, early treatment can change everything.

Want to learn more? Follow my blog series for more insights on Lyme disease diagnosis and care—or reach out to my office if you’re looking for answers.
You deserve to be heard.

Related Articles:

Relying on a negative Lyme disease test can prove deadly

Don’t wait for a positive Lyme disease test

Can’t trust single dose of doxycycline to prevent Lyme disease

_______________

**Comment**

A very needed article with crucial information for all to understand.

Testing for Lyme/MSIDS is abysmal.  Clinical judgement is required; however, doctors receive little training for tick-borne infections and whatever training they do receive is antiquated and biased.  The fact the needle hasn’t budged in 40 years is proof of this fact.

Dr. Cameron is an example of an independent doctor who could save your life.  He’s also a Lyme-literate doctor who has studied under ILADS and who has years of experience treating this.  Like many of his colleagues, he’s been attacked by the state medical board – which is common for these doctors because they do not partake in the globalist idea for ‘consensus-based’ medicine – which turns doctors into robots who blindly follow dictates from bureaucrats who are profiting from conflicts of interests including patents, drugs, and other metabolomics. 

Due to the horrific lack of education on all things Lyme/MSIDS, there is a parallel group to the tyrannical IDSA (Infectious Diseases Society of America) called ILADS (International Lyme and Associated Diseases Society) which holds their own medical conferences to educate doctors on what is happening in reality with Lyme/MSIDS and through independent, global research that the IDSA simply ignores or maligns. Their next conference, “The Complexity of Lyme: Diagnosing and Treating Tick-Borne and Related Diseases,” is June 7-8 in Philadelphia.

Our conference will include:

  • Introduction to diagnosing and treating vector-borne diseases
  • Case discussions with experts
  • Advanced topics in clinical treatments such as PANS/PANDAS, Mold toxicity, MCAS, supportive natural therapies and more.
  • Exhibitors showcasing medical services
  • CME credit available

The conference is open to healthcare professionals. Students enrolled in a medical degree program and PhD candidates conducting Lyme-related research are also eligible to attend and qualify for discounted rates. Email conference@ilads.org for more information.

Category:

Lyme, research, Testing, Treatment

Tuttle Destroys NASEM’s Lyme Disease Report

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/

The IDSA’s Post Treatment Lyme Disease Syndrome was not good enough!

Carl Tuttle
Hudson, NH, United States
May 15, 2025

The IDSA’s Post Treatment Lyme Disease Syndrome was not good enough so now we have yet another distraction avoiding the elephant in the room (chronic Lyme) called Lyme IACI; “Lyme Infection-Associated Chronic Illness.”

That should add another decade to the denial of chronic Lyme allowing the pharmaceutical industrial complex to roll out its Lyme vaccine and payouts in the form of patent royalties to all those responsible for this crime against humanity. It was that rush to create a vaccine early in the discovery phase of the epidemic that led to the deliberate mishandling of the disease. All the eggs were put into the vaccine basket before a cure was researched and uncovered. We have been dealing with an antibiotic resistant/tolerant superbug but the vaccine money grab was far too lucrative to pass up. Covid proved to us all that our Public Health Officials will do or say anything for the sake of a vaccine; “Safe and Effective“??????

Please take a moment to read the following inquiry sent to Marcia McNutt, President of the National Academy of Sciences regarding a recent publication referencing the latest acronym “Lyme IACI.”

Image of McNutt was found here: https://www.nasonline.org/directory-entry/marcia-mcnutt-6apamq/

Inquiry to Marcia McNutt:

———- Original Message ———-

From: CARL TUTTLE <runagain@comcast.net>
To: “mmcnutt@nas.edu” <mmcnutt@nas.edu>, “vdzau@nas.edu” <vdzau@nas.edu>
Cc: “wkearney@nas.edu” <wkearney@nas.edu>, “dmay@nas.edu” <dmay@nas.edu>, “amacdonald@nas.edu” <amacdonald@nas.edu>
Date: 05/14/2025 8:50 AM EDT
Subject: The National Academies Press; Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illness

The National Academies Press

Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illness (“Lyme IACI”)
https://nap.nationalacademies.org/read/28578/chapter/1

Marcia McNutt

President of the National Academy of Sciences and Chair of the National Research Council

“Most of my current activity centers around meta science – how to shape the culture and conduct of science to build trust, excellence, inclusiveness, and integrity.” – Marcia McNutt

Dear Marcia McNutt,

After reading through your Biosketch you seem to have the capability to detect scientific fraud. Would suppressing evidence of antibiotic resistance (for the sake of a vaccine) constitute a crime? Please take a moment to read the following inquiry addressed to Grace E. Marx, MD Medical Epidemiologist, Centers for Disease Control and Prevention. If the scientific references/evidence I provide were not suppressed the focus would have been on finding effective antimicrobials to treat this antibiotic resistant/tolerant superbug.

Question: Has the National Academy of Sciences under your direction just had the wool pulled over their eyes?

A response to this inquiry is requested.

Carl Tuttle
Independent Researcher
Hudson, NH

Cc: Victor J. Dzau President, National Academy of Medicine

William Kearney Executive Director of the Office of News and Public Information

David May Director, National Academies Press

Alphonse MacDonald Publisher, National Academies Press

Inquiry to: Grace E. Marx, MD Medical Epidemiologist, Centers for Disease Control and Prevention

———- Original Message ———-

From: CARL TUTTLE <runagain@comcast.net>
To: “grace.marx@cuanschutz.edu” <grace.marx@cuanschutz.edu>, “gmarx@cdc.gov” <gmarx@cdc.gov>
Cc: “katrina.rouse@usdoj.gov” <katrina.rouse@usdoj.gov>, “jonathan.kanter@usdoj.gov” <jonathan.kanter@usdoj.gov>
Date: 10/25/2024 9:11 AM EDT

Subject: Tick-Borne Diseases and Associated Illnesses, Community Engagement Series: Mental Health and Neurological Effects

Tick-Borne Diseases and Associated Illnesses, Community Engagement Series: Mental Health and Neurological Effects
https://www.hhs.gov/oidp/initiatives/tick-borne-diseases-associated-illnesses-national-community-engagement-initiative/index.html

3:00 pm – 3:20 pm   A Clinician Toolkit: Improving Care for Patients with Prolonged Symptoms and Concerns about Lyme Disease By Grace E. Marx, MD Medical Epidemiologist, Centers for Disease Control and Prevention

Dear Dr. Marx,

I listened to your presentation yesterday with great interest and I must congratulate you for your outstanding performance in suppressing all evidence of persistent infection; chronic Lyme disease.

We have studies proving persistent infection after antibiotic treatment for mice, dogs, ponies,  monkeys, cows, iris biopsy, and ligamentous tissue but if you perform a simple Google search for the following statement, “There is no convincing scientific evidence that chronic Lyme exists” you will find the top search results are connected to “elements of academic medicine” involved in the denial of the late stage Lyme epidemic.

In 1991 the Lyme disease organism, Borrelia burgdorferi, was grown from the cerebrospinal fluid of Lyme patient Vicki Logan at the Centers for Disease Control in Fort Collins, Colorado despite prior treatment with intravenous antibiotics. The patient died when the insurer refused additional IV antibiotics. Here is a copy of Logan’s CDC positive culture report for your review.

(Vicky Logan’s Chronic Lyme Autopsy results Page #1, 2, 3, 4, 5, 6, 7)

There are 700 peer-reviewed publications referencing persistent infection and in a 2018 study all patients were culture positive even after multiple years on antibiotics so there was no relief from current antimicrobials. Some of these patients had taken as many as eleven different types of antibiotics.

Thirty-four years ago Dr. Allen Steere identified chronic Lyme disease which should have set off a red flag prompting an immediate search for better antimicrobials but then did a 180° as he became principal investigator (PI) of the Phase 3 clinical trial for the first Lyme disease vaccine. So all the eggs were put into the vaccine basket while a campaign was orchestrated to discredit the sick and disabled patient population along with the courageous clinicians attempting to help these patients. Apparently, a chronic relapsing seronegative disease did not fit the business model of patent royalties, vaccine development and pharmaceutical profits.

Here is Dr. Steere’s 1990 publication summary for your review:

The New England Journal of Medicine 

Published November 22, 1990

Chronic neurologic manifestations of Lyme disease
https://www.nejm.org/doi/full/10.1056/NEJM199011223232102

The chart below summarizes Lyme research funded by the NIH and only 2.5% has been allocated for treatment:

[Click on the link above to view the chart]

For the record there are many infections requiring long-term antibiotics so why Klempner stopped his NIH funded antibiotic treatment trials for Lyme after 90 days makes absolutely no sense whatsoever:

From the following publication:

Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease
https://www.dovepress.com/benefit-of-intravenous-antibiotic-therapy-in-patients-referred-for-tre-peer-reviewed-fulltext-article-IJGM

Infections requiring long-term antibiotics:

[Download the article and View Table 4 as there are nine infections listed] 

Lyme misdiagnosed/undiagnosed for months, years or decades is far more incapacitating than “acute” Lyme and 2-4 weeks of antibiotics does not scratch the surface of this well-established/immune suppressive infection. These are the patients who need help the most but have been excluded in research for decades. There are countless stories of patients seroconverting after the initial few doses of Doxycycline and now that a toxin has been identified that puts Lyme disease in an altogether different category of infection:

Toxins 

Published: 21 May 2024

Borrelia burgdorferi 0755, a Novel Cytotoxin with Unknown Function in Lyme Disease
https://www.mdpi.com/2072-6651/16/6/233

So it would appear that one way to get a medical association (AMA) to go along with the suppression of evidence is to throw them a boatload of money… five million taxpayer dollars to be exact for a so-called IDSA biased “Clinician Toolkit”  (CDC grant number  NU50CK000597)

This controlling of the narrative has caused unimaginable pain and suffering all across America as insurance companies refuse to pay for long-term treatment, personal bankruptcies from out-of-pocket expenses to treat chronic infection, suicides from despair all while Valneva Received FDA Fast Track Designation for its Lyme Disease Vaccine.

Chronic Lyme must be recognized and finally addressed with 100% attention to effective antimicrobials for all stages of disease.

Question:

Is collusion to control the narrative through suppression of the truth, facts and scientific references a criminal offense?

Carl Tuttle
Hudson, NH

Cc: Assistant Attorney General Jonathan Kanter, Attorney Katrina Rouse

Attorneys for the United States Antitrust Division

Assistant Attorney General Jonathan Kanter Announces Task Force on Health Care Monopolies and Collusion
https://www.justice.gov/opa/pr/assistant-attorney-general-jonathan-kanter-announces-task-force-health-care-monopolies-and

“Every year, Americans spend trillions of dollars on health care, money that is increasingly being gobbled up by a small number of payers, providers and dominant intermediaries that have consolidated their way to power in communities across the country,” said Assistant Attorney General Jonathan Kanter of the Justice Department’s Antitrust Division. “Led by Katrina Rouse, the task force will identify and root out monopolies and collusive practices that increase costs, decrease quality and create single points of failure in the health care industry.”

2nd email sent to Marcia McNutt:

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “mmcnutt@nas.edu” <mmcnutt@nas.edu>, “vdzau@nas.edu” <vdzau@nas.edu>
Cc: “wkearney@nas.edu” <wkearney@nas.edu>, “dmay@nas.edu” <dmay@nas.edu>, “amacdonald@nas.edu” <amacdonald@nas.edu>
Date: 05/15/2025 9:14 AM EDT
Subject: Re: The National Academies Press; Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illness

Dear Marcia McNutt,

Please see the inquiry below addressed to Dr. Raymond Dattwyler …..

Dr. Raymond Dattwyler owns 24 patents for Lyme disease that include diagnostic testing and vaccines both live bacteria and oral. Raymond Dattwyler, Benjamin Luft, et al have some interesting comments in their application for a Lyme related patent… 

Dattwyler et al. United States Patent 7,605,248 October 20, 2009
https://www.dropbox.com/scl/fi/1yxcrwjfhhw4q47999dug/Raymond-Dattwyler-Grant-2R01AI37256-05A1-from-the-National-Institute-of-Allergy-and-Infectious-Diseases..docx

“Currently, Lyme Disease is treated with a range of antibiotics, e.g., tetracyclines, penicillin and cephalosporins. However, such treatment is not always successful in clearing the infection. Treatment is often delayed due to improper diagnosis with the deleterious effect that the infection proceeds to a chronic condition, where treatment with antibiotics is often not useful. One of the factors contributing to delayed treatment is the lack of effective diagnostic tools.”

2022 Inquiry to Dr. Raymond Dattwyler: 

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>To: Raymond_Dattwyler@nymc.eduCc: npjvaccines@nature.com, abarrett@utmb.edu, R.W.Titball@exeter.ac.uk, mgomesso@uthsc.eduDate: 01/06/2023 2:46 PM EST
Subject: The year that shaped the outcome of the OspA vaccine for human Lyme disease

npj Vaccines Jan 2022

The year that shaped the outcome of the OspA vaccine for human Lyme disease
https://www.nature.com/articles/s41541-022-00429-5
Raymond J. Dattwyler & Maria Gomes-Solecki

Department of Microbiology and Immunology
New York Medical College
Valhalla, NY
Raymond J. Dattwyler, Corresponding Author

Dear Dr. Dattwyler,

I read your manuscript with great interest as you call attention to a treatment-resistant Lyme arthritis with “no evidence of DNA” found in the joints of patients after antibiotic treatment.

For some strange reason however, I could not find the following 1995 publication within your paper identifying treatment-resistant neuroborreliosis: 

European Neurology 1995

Seronegative Chronic Relapsing Neuroborreliosis
https://www.karger.com/Article/Abstract/117104
Lawrence C., Lipton R.B., Lowy F.D., Coyle P.K.d

Abstract

We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen. 

In fact, Dr. Dattwyler there seems to be a great deal of “treatment-resistant” evidence published in multiple journals over the past three decades:

Peer Reviewed Evidence of Persistence of Lyme Disease Spirochete Borrelia burgdorferi and Tick-Borne Diseases (700 References)
https://www.dropbox.com/s/n09sk90eo6xz7ua/700%20articles%20LYME%20EvidenceofPersistence-V2.pdf?dl=0

So that brings me to the reason for this email…

Question:

Does a chronic relapsing seronegative disease fit the vaccine model? If not, would that, in and of itself, be the hidden reason for denying chronic (treatment-resistant) Lyme disease for almost three decades? In other words, patent royalties and pharmaceutical profits over lifesaving care?

A response to this inquiry is requested.

Carl Tuttle
Hudson, NH

Cc: Alan D.T. Barrett, PhD Editor-in-Chief
Rick Titball, PhD, DSc, Deputy Editor

Letter to the Editor of the BMJ published June 2020
https://www.bmj.com/content/369/bmj.m1041/rr-1

_______________

**Comment**

Once again, kudos and a big ‘thank you’ go out to Lyme advocate Carl Tuttle for being a junk yard dog that refuses to let go of the jugular vein.

Tuttle has been tireless in writing letters and exposing Oz behind the Lyme curtain: repeated denial and cover-up of chronic, relapsing Lyme disease.

I posted the ‘new treatments for Lyme Infection-Associated Chronic Illnesses’ here:   https://madisonarealymesupportgroup.com/2025/05/09/charting-a-path-towards-new-treatments-for-chronic-lyme-disease/

I had a sinking feeling then that this would amount to nothing but further entrenchment in the old, antiquated and unscientific Lyme narrative.  It appears I was correct.  I included the old 2014 interview with Willy Burgdorfer, which I repost here, where he states research must be started over at square one because the same people have been doing the research and coming up with the same results – nothing!

http://  Approx. 5 Min

Willy Burgdorfer 2014

“Money goes to people that have for the past 30 years produced the same thing.  Nothing.” ~  Willy Burgdorfer

Well, it’s now been a total of more than 40 years and the same thing is being produced, which is nothing.

For more:

Category:

Activism, Lyme, research

‘Must Hear’ Dr. Hatfill Interview

http://  Approx. 1 Hour

Dr. Steven Hatfill Blows Whistle on COVID Treatments, Gene Therapy Injections, and Research Fraud

“They lied!”

Podcast by Dana Parish

May, 2025

This is one of the most shocking interviews I’ve ever done. Dr. Steven Hatfill, renowned virologist, bioweapons expert, author, and senior scientific adviser to HHS, joins me to reveal the debacle behind COVID, the ‘vaccine,’ early treatments, and what really happened behind the scenes during the pandemic.

Hatfill was wrongfully accused of the anthrax attacks in the early 2000s and later exonerated, earning a multi-million dollar settlement from the US Government. But that didn’t stop him from stepping back into the fire. During the first Trump administration, he became a fierce advocate for early COVID treatment while the mainstream medical establishment tried to silence him.

In this episode, he lays out the evidence on how COVID was bioengineered, early treatments were suppressed, the vaccines were entirely misrepresented, and much more.

_____________

**Comment**

No, you are not losing your mind.  I’ve posted this podcast before here:  https://madisonarealymesupportgroup.com/2025/05/14/study-confirms-covid-shots-laced-with-cancer-causing-dna/

I just felt it important enough to repost as some might have missed it.

And you don’t want to miss this one.

Dr. Hatfill answers all of Parish’s questions humbly and honestly.  I’m happy to report that everything posted on this website on the COVID chapter aligns with what Dr. Hatfill says in this interview.  I am indebted to doctors and researchers who shared prolifically on Linkedin early on.  Many of these experts are retired or not employed by the government and could speak freely.  Unfortunately, one by one, Linked in kicked these truth-tellers off the platform until one day I too was ‘disappeared.’  

Shame on platforms for censoring experts sharing information that could have saved lives.

The entire COVID chapter was mishandled from the start and there’s many people and organizations who need to be brought to justice over the fraud, deceit, and damage done in virtually every area.

And now, the IPAK-EDU White Paper 2025-ENDEUA states that when corrected efficacy curves and suppressed risks are taken into account, the mRNA covid shots fail the EUA standard.  The shots were based upon interim data from large-scale Phase III trials. The legal standard under §564 of the Federal Food, Drug, and Cosmetic Act requires that a product may be authorized for emergency use only if it is “reasonable to believe” that the product “may be effective” against a life-threatening condition, that the known and potential benefits outweigh the known and potential risks, and that no adequate alternatives are available. This report demonstrates, through a rigorous retrospective analysis, that these criteria were never met.

Trust me when I say, you need to hear this interview.  Please also share this widely, particularly to those who are still in the dark or need to hear it from an ‘expert.’  Hatfill knows his stuff.

For articles on the many topics Hatfill covers:

COVID is lab made:

Suppression of early, successful treatment:

How spike protein behaves in the body:

Is the shot gene therapy?  YES

Why was mRNA the government choice for COVID?

    • There are 9,613 patents licensed to giants in biotech and the US government
    • BARDA and DARPA have had a torrid love affair with mRNA for decades
    • A retrospective cohort study found the US government invested at least $31.9B to develop, produce, and purchase mRNA covid-19 shots, including sizable investments in the three decades before the pandemic through March 2022. 
    • While the study claims “millions of lives were saved,” the truth is the experimental, COVID gene therapy injections saved ZERO lives.

Links between COVID shots & Cancer

Nasal sprays to prevent COVID:

Persecution of doctors & health professionals who defied the global narrative:

Category:

Activism, research, Treatment, vaccines, Viruses